294 related articles for article (PubMed ID: 29946775)
21. DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas.
Paul Y; Mondal B; Patil V; Somasundaram K
Clin Epigenetics; 2017; 9():32. PubMed ID: 28392842
[TBL] [Abstract][Full Text] [Related]
22. ACTC1 as an invasion and prognosis marker in glioma.
Ohtaki S; Wanibuchi M; Kataoka-Sasaki Y; Sasaki M; Oka S; Noshiro S; Akiyama Y; Mikami T; Mikuni N; Kocsis JD; Honmou O
J Neurosurg; 2017 Feb; 126(2):467-475. PubMed ID: 27081897
[TBL] [Abstract][Full Text] [Related]
23. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
[TBL] [Abstract][Full Text] [Related]
24. Antiangiogenic therapy for high-grade glioma.
Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
[TBL] [Abstract][Full Text] [Related]
25. A Metabolic Inhibitory Cocktail for Grave Cancers: Metformin, Pioglitazone and Lithium Combination in Treatment of Pancreatic Cancer and Glioblastoma Multiforme.
Elmaci İ; Altinoz MA
Biochem Genet; 2016 Oct; 54(5):573-618. PubMed ID: 27377891
[TBL] [Abstract][Full Text] [Related]
26. Beyond glucose: alternative sources of energy in glioblastoma.
Caniglia JL; Jalasutram A; Asuthkar S; Sahagun J; Park S; Ravindra A; Tsung AJ; Guda MR; Velpula KK
Theranostics; 2021; 11(5):2048-2057. PubMed ID: 33500708
[TBL] [Abstract][Full Text] [Related]
27. Altered Elemental Distribution in Male Rat Brain Tissue as a Predictor of Glioblastoma Multiforme Growth-Studies Using SR-XRF Microscopy.
Planeta K; Setkowicz Z; Czyzycki M; Janik-Olchawa N; Ryszawy D; Janeczko K; Simon R; Baumbach T; Chwiej J
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054889
[TBL] [Abstract][Full Text] [Related]
28. Targeting osteopontin suppresses glioblastoma stem-like cell character and tumorigenicity in vivo.
Lamour V; Henry A; Kroonen J; Nokin MJ; von Marschall Z; Fisher LW; Chau TL; Chariot A; Sanson M; Delattre JY; Turtoi A; Peulen O; Rogister B; Castronovo V; Bellahcène A
Int J Cancer; 2015 Sep; 137(5):1047-57. PubMed ID: 25620078
[TBL] [Abstract][Full Text] [Related]
29. Glioblastoma heterogeneity and cancer cell plasticity.
Friedmann-Morvinski D
Crit Rev Oncog; 2014; 19(5):327-36. PubMed ID: 25404148
[TBL] [Abstract][Full Text] [Related]
30. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms regulating glioma invasion.
Paw I; Carpenter RC; Watabe K; Debinski W; Lo HW
Cancer Lett; 2015 Jun; 362(1):1-7. PubMed ID: 25796440
[TBL] [Abstract][Full Text] [Related]
32. Proteins and protein pattern differences between glioma cell lines and glioblastoma multiforme.
Vogel TW; Zhuang Z; Li J; Okamoto H; Furuta M; Lee YS; Zeng W; Oldfield EH; Vortmeyer AO; Weil RJ
Clin Cancer Res; 2005 May; 11(10):3624-32. PubMed ID: 15897557
[TBL] [Abstract][Full Text] [Related]
33. PDGF Family Expression in Glioblastoma Multiforme: Data Compilation from Ivy Glioblastoma Atlas Project Database.
Cantanhede IG; de Oliveira JRM
Sci Rep; 2017 Nov; 7(1):15271. PubMed ID: 29127351
[TBL] [Abstract][Full Text] [Related]
34. The role of Stat3 in glioblastoma multiforme.
Luwor RB; Stylli SS; Kaye AH
J Clin Neurosci; 2013 Jul; 20(7):907-11. PubMed ID: 23688441
[TBL] [Abstract][Full Text] [Related]
35. Tissue Proteome Analysis of Different Grades of Human Gliomas Provides Major Cues for Glioma Pathogenesis.
Gollapalli K; Ghantasala S; Atak A; Rapole S; Moiyadi A; Epari S; Srivastava S
OMICS; 2017 May; 21(5):275-284. PubMed ID: 28481733
[TBL] [Abstract][Full Text] [Related]
36. Investigation of Inter- and Intratumoral Heterogeneity of Glioblastoma Using TOF-SIMS.
Gularyan SK; Gulin AA; Anufrieva KS; Shender VO; Shakhparonov MI; Bastola S; Antipova NV; Kovalenko TF; Rubtsov YP; Latyshev YA; Potapov AA; Pavlyukov MS
Mol Cell Proteomics; 2020 Jun; 19(6):960-970. PubMed ID: 32265293
[TBL] [Abstract][Full Text] [Related]
37. Absence of IDH1-R132H mutation predicts rapid progression of nonenhancing diffuse glioma in older adults.
Olar A; Raghunathan A; Albarracin CT; Aldape KD; Cahill DP; Powell SZ; Goodman JC; Fuller GN
Ann Diagn Pathol; 2012 Jun; 16(3):161-70. PubMed ID: 22197544
[TBL] [Abstract][Full Text] [Related]
38. Hypoxia induces peroxisome proliferator-activated receptor α (PPARα) and lipid metabolism peroxisomal enzymes in human glioblastoma cells.
Laurenti G; Benedetti E; D'Angelo B; Cristiano L; Cinque B; Raysi S; Alecci M; Cerù MP; Cifone MG; Galzio R; Giordano A; Cimini A
J Cell Biochem; 2011 Dec; 112(12):3891-901. PubMed ID: 21866563
[TBL] [Abstract][Full Text] [Related]
39. Fatty acid binding protein 4 is expressed in distinct endothelial and non-endothelial cell populations in glioblastoma.
Cataltepe O; Arikan MC; Ghelfi E; Karaaslan C; Ozsurekci Y; Dresser K; Li Y; Smith TW; Cataltepe S
Neuropathol Appl Neurobiol; 2012 Aug; 38(5):400-10. PubMed ID: 22093167
[TBL] [Abstract][Full Text] [Related]
40. Proteomic level changes associated with S3I201 treated U87 glioma cells.
Jain R; Atak A; Yeola A; Srivastava S
J Proteomics; 2017 Jan; 150():341-350. PubMed ID: 27565396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
